## Aminoglycoside Uptake and Oxygen Dependence **Key Point:** Aminoglycosides require **aerobic conditions and active transport** to enter bacterial cells. They are taken up via an oxygen-dependent, energy-dependent (Phase II) active transport mechanism that is absent or non-functional in anaerobic bacteria. **High-Yield:** This oxygen-dependent uptake is the PRIMARY reason aminoglycosides are: - Ineffective against **obligate anaerobes** (Bacteroides, Clostridium, Peptostreptococcus) - Ineffective against **facultative anaerobes in anaerobic environments** (e.g., Enterococcus in the GI tract lumen) - Ineffective against **gram-positive cocci** in certain contexts (though gram-positive aerobes like Staphylococcus are usually susceptible if oxygen is present) ### Mechanism of Aminoglycoside Entry | Phase | Oxygen | Energy | Uptake Rate | Clinical Relevance | |-------|--------|--------|-------------|--------------------| | Phase I | Not required | Not required | Slow, non-specific | Occurs in anaerobes but insufficient for bactericidal effect | | Phase II | **Required** | **Required** (electron transport chain) | Rapid, efficient | **Main bactericidal pathway; absent in anaerobes** | **Mnemonic:** **AERO-G** — Aminoglycosides require AERObes for effective uptake and Gram-negative organisms are most susceptible (though gram-positives are also killed aerobically). **Clinical Pearl:** Enterococcus faecalis is intrinsically resistant to aminoglycosides when grown anaerobically or in the absence of aerobic respiration, explaining why aminoglycosides alone do not treat enterococcal infections — they must be combined with cell-wall-active agents (penicillin or vancomycin) to allow drug entry. [cite:KD Tripathi 8e Ch 48]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.